Bicycle Therapeutics (BCYC) Other Operating Expenses (2018 - 2026)

Bicycle Therapeutics (BCYC) has 5 years of Other Operating Expenses data on file, last reported at -$2.0 million in Q2 2026.

• Quarterly Other Operating Expenses rose 15.21% year-over-year to -$2.0 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was -$9.6 million (up 0.71% YoY) and the FY2025 annual result came in at -$9.6 million, down 5.86% from the prior year.
• Other Operating Expenses climbed to -$2.0 million in Q2 2026, from -$2.5 million in the prior quarter.
• In the past five years, Other Operating Expenses ranged from a high of -$1.9 million in Q2 2024 to a low of -$2.6 million in Q4 2024.
• A 3-year average of -$2.3 million and a median of -$2.4 million in 2025 frame the typical range for Other Operating Expenses.
• Annual changes were most pronounced in 2025 — Other Operating Expenses slipped 21.45% — and 2026, when it climbed 15.21%.
• Tracing BCYC's Other Operating Expenses over 3 years: stood at -$2.6 million in 2024, then changed by 0.0% to -$2.6 million in 2025, then advanced by 23.65% to -$2.0 million in 2026.
• The last three Other Operating Expenses figures came in at -$2.0 million (Q2 2026), -$2.5 million (Q1 2026), and -$2.6 million (Q4 2025), per Business Quant data.